Diffuse Large B-Cell Lymphoma | Topics

 
Reid Merryman, MD, on Pre- and Post-Transplant Data for Patients with DLBCL
January 23, 2021

Merryman explains the value of evaluating separate transplant-related questions for patients with relapsed or refractory diffuse large B-cell lymphoma.

Reid Merryman, MD, on Study Findings Investigating Prognostic Value of ctDNA for Patients with DLBCL
January 21, 2021

Thought leader detailed the findings from an oral presentation investigating patients with relapsed or refractory diffuse large B-cell lymphoma.

Reid Merryman, MD, Discusses Autologous Stem Cell Transplantation for Patients with DLBCL
January 13, 2021

Merryman provided background for the study design investigating patients with relapsed or refractory diffuse large B-cell lymphoma.